• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Philips announces European launch of HeartStart Intrepid defib

Philips announces European launch of HeartStart Intrepid defib

August 19, 2019 By Danielle Kirsh

Royal Philips (NYSE:PHG) today announced that it launched its HeartStart Intrepid monitor/defibrillator with IntelliSpace Connect in Europe and other worldwide markets.

HeartStart Intrepid allows caregivers to evaluate and treat patients in demanding medical emergencies. The device is available in Europe and select markets in Asia and Africa.

“First responders don’t often know what to expect when they arrive at the scene of an emergency, so they have to be equipped and ready to handle anything that may come up in the field,” therapeutic care business leader Arman Voskerchyan said in a press release. “A full range of monitoring capabilities and decision support tools let emergency staff quickly evaluate and treat patients in life-threatening situations. Enhanced connectivity between care settings helps to streamline communication and improve clinical workflow for caregivers, ultimately allowing them to provide patients with better care.”

Philips’s HeartStart Intrepid is lightweight, portable and rugged and can be used in emergency medical service, emergency departments and intra-hospital transport. It features vital patient monitoring parameters and diagnostic measurements to help clinicians decide the best care plan for each patient. It can help clinicians deliver better quality CPR with feedback and guidance for compressions and ventilations. It also features the Traumatic Brain Injury (TBI) Advisory that is based on key patient vital sign assessment to give visual guidance and prevent complications in patients suspected to have TBI.

The HeartStart Intrepid monitor/defibrillator’s IntelliSpace Connect is a cloud-based data management solution that can help clinicians set up coordinated care for patients in the critical care setting. The system supports the integration of emergency event data into electronic patient care reporting and electronic medical records to give doctors accurate event documentation for billing, according to the company. It also offers secure data storage for post-event review.

IntelliSpace Connect is accessed through a browser and powered through Philips HealthSuite.

Filed Under: Cardiovascular, Hospital Care Tagged With: Philips

More recent news

  • Zimmer Biomet to expand robotic suite with Monogram acquisition
  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy